Linagliptin Impurity JX 基本信息
| 中文名稱 | Linagliptin Impurity JX |
|---|---|
| 中文同義詞 | 利格列汀雜質(zhì)JX;利拉利汀雜質(zhì)109;利格列汀雜質(zhì) 115;(R)-N-(1-(7-(丁-2-炔-1-基)-3-甲基-1-((4-甲基喹唑啉-2-基)甲基)-2,6-二氧代-2-,3,6,7-四氫-1H-嘌呤-8-基)哌啶-3-基)甲酰胺(利格列汀雜質(zhì));N-[1-[7-(2-丁炔-1-基)-2,3,6,7-四氫-3-甲基-1-[(4-甲基-2-喹唑啉基)甲基]-2,6-二氧基-1H-嘌呤-8-基]-3-哌啶基]甲酰胺;利格列汀進(jìn)口標(biāo)準(zhǔn)雜質(zhì);N-(1-(7-(2-丁炔-1-基)-3-甲基-1-((4-甲基喹唑啉-2-基)甲基)-2,6-二氧代-2,3,6,7-四氫-1H-嘌呤-8-基)哌啶-3-基)甲酰胺 (利格列汀雜質(zhì));利格列汀雜質(zhì)Z18 |
| 英文名稱 | Linagliptin Impurity JX |
| 英文同義詞 | Linagliptin Impurity JX;N-[1-[7-(2-Butyn-1-yl)-2,3,6,7-tetrahydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-2,6-dioxo-1H-purin-8-yl]-3-piperidinyl]formamide;Linagliptin JX;Linagliptin Impurity 109;Linagliptin Impurity 115;(R)-N-(1-(7-(But-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)formamide (Linagliptin Impurity);Formamide, N-[1-[7-(2-butyn-1-yl)-2,3,6,7-tetrahydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-2,6-dioxo-1H-purin-8-yl]-3-piperidinyl]-;N-(1-(7-(But-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)formamide (Linagliptin impurity) |
| CAS號 | 2137744-33-1 |
| 分子式 | C26H28N8O3 |
| 分子量 | 500.55 |
| EINECS號 | |
| 相關(guān)類別 | |
| Mol文件 | 2137744-33-1.mol |
| 結(jié)構(gòu)式 |  |
Linagliptin Impurity JX 性質(zhì)
| 沸點(diǎn) | 734.5±70.0 °C(Predicted) |
|---|---|
| 密度 | 1.39±0.1 g/cm3(Predicted) |
| 酸度系數(shù)(pKa) | 15.57±0.20(Predicted) |
安全信息
| 更新日期 | 產(chǎn)品編號 | 產(chǎn)品名稱 | CAS號 | 包裝 | 價格 |
|---|---|---|---|---|---|
| 2026/06/05 | XW02213774433101 | (R)-N-(1-(7-(丁-2-炔-1-基)-3-甲基-1-((4-甲基喹唑啉-2-基)甲基)-2,6-二氧代-2-,3,6,7-四氫-1H-嘌呤-8-基)哌啶-3-基)甲酰胺（利格列汀雜質(zhì)） | 2137744-33-1 | 50MG | 433元 |